Business
Director Dealings / Market Share Transactions
Director Dealings / Market Share Transactions.
About this update from Oxford Biomedica Plc
[{"type":"text","content":"\n \n \n RNS Number : 8903R\n Oxford Biomedica PLC\n 02 July 2020\n \n \n \n \n \n \n \n \n \n \n \n \n \n Director Dealings / Market Share Transactions\n \n \n \n \n \n \n Oxford, UK - 02 July 2020:\n \n \n Oxford BioMedica plc (\"Oxford BioMedica\" or \"the Group\") (LSE: OXB\n \n a leading gene and cell therapy group, today announces that Dr. Andrew Heath, a Non-Executive Director of the Group, purchased 2000 ordinary shares of 50p each (\"Ordinary Shares\") in the Company on 30 June 2020 on the London Stock Exchange at a price of 705.8p and sold 3,000 and 1,000 Ordinary Shares on 30 June 2020 on the London Stock Exchange at a price of 705.3p and 703.5p respectively in order to transfer shares into his ISA.\n \n \n \n \n \n 3,000 Ordinary Shares were purchased by Dr. Heath's wife (Eva Lackner) on 30 June 2020 on the London Stock Exchange at a price of 706.9p and are therefore considered a beneficial holding of Dr. Heath. \n \n \n \n \n \n Following these purchases and sale Dr. Andrew Heath holds 56,000 shares representing 0.07% of the Company.\n \n \n \n \n \n The below notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail of the number of Ordinary Shares purchased.\n \n \n \n \n \n 1.\n \n \n Details of the person discharging material responsibilities/person closely associated\n \n \n \n \n \n a.\n \n \n Name\n \n \n Dr. Andrew Heath\n \n \n \n \n \n 2.\n \n \n Reason for the notification\n \n \n \n \n \n a.\n \n \n Position/status\n \n \n \n Non-Executive Director\n \n \n \n \n \n b.\n \n \n Initial notification /amendment\n \n \n Initial notification\n \n \n \n \n \n 3.\n \n \n Details of the issuer, emission allowance, market participant, auction platform, auctioneer or auction monitor\n \n \n \n \n \n a.\n \n \n Name\n \n \n Oxford Biomedica plc\n \n \n \n \n \n b.\n \n \n Legal Entity Identifier\n \n \n 213800S1GVQNXQ15K851\n \n \n \n \n \n 4.\n \n \n Details of the transaction(s); section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted\n \n \n \n \n \n a.\n ...